Some of the most appealing payers today are housing and pharmaceutical companies. Persimmon, for example, is considered to be the king of dividends, yielding 6.4%. Many analysts believe that the only thing that would break the Persimmon dividend would be a complete collapse of the housing market.
BHP Billiton bucked the trend in the mining industry, managing to keep its dividend high even during the financial crisis. The company is still performing well, compared to others in the industry, and looks like it may be able to keep dividends high even in the current commodities slump.
Pharmaceuticals company GlaxoSmithKline looks set to keep payouts high. The company has decided to put off any big decisions for the business for the foreseeable future, holding dividends high and trying to keep expenses low. However, some analysts are concerned that this is a short term stalling measure, and that there are fundamental problems with the share that need to be addressed. The company has an attractive yield for now, but their third quarter results failed to impress. As a short term investment, GlaxoSmithKline could be a good option, but something is going to have to give with the company eventually, and a dividend cut seems like the most likely option.